Skip to main content
. Author manuscript; available in PMC: 2012 Oct 27.
Published in final edited form as: Neuroscience. 2011 Aug 6;194:189–194. doi: 10.1016/j.neuroscience.2011.08.010

Figure 2.

Figure 2

Effects of Valproate (VPA) on striatal dopamine (DA) and DA turnover following administration of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP). Treatment with VPA increased striatal DA levels (A), as measured by high pressure liquid chromatography (HPLC) 2 weeks after the final MPTP injection, but had no effect on DA turnover (B) compared to control mice. . **p< 0.01, ***: p< 0.001.